Market Overview:
The global sotalol drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiac arrhythmias and the rising demand for effective and safe treatment options. By type, the tablet segment is expected to lead the global sotalol drug market during the forecast period, owing to its high adoption rates across regions. By application, ventricular arrhythmias are expected to account for a major share of the global sotalol drug market during the forecast period, owing to their high prevalence globally.
Product Definition:
Sotalol is a drug used to treat heart conditions. It helps to keep the heart rhythm regular and can help to prevent chest pain.
Tablet:
Tablet is a dosage form of Sotalol used for the treatment of cardiac arrest and severe bradycardia. It's an off-label drug usage, approved by the Food and Drug Administration (FDA) in 1990 for treatment of cardiac arrest caused due to sudden heart attacks. The tablet is available in two forms: film-coated and uncoated.
Oral Solution:
Oral solution is a liquid medication given to patients that are unable to take pills. The oral solution contains the active ingredient and it's mixed with inert substances like lactose or mannitol. These solutions are available in different forms such as syrups, tablets, and liquids. The most common type of oral solutions used today is syrup which can be easily taken by children and pets alike.
Application Insights:
The supraventricular arrhythmia segment held the largest revenue share in 2017. This can be attributed to the increasing prevalence of conditions such as heart valve problems, rheumatic heart disease and other cardiac disorders. Sotalol is used for treating bradyarrhythmia and tachyarrhythmia, which are associated with a high risk of stroke or blood vessel blockage. The drug is also used for the treatment of patients suffering from Raynaud¢â‚¬â„¢s syndrome due to its anti-inflammatory properties. Thus, rising awareness about these benefits among healthcare professionals and consumers will boost market growth during the forecast period.
Sotalol injection is approved by U.
Regional Analysis:
North America dominated the global market in 2017. The high prevalence of cardiac disorders, rising geriatric population, and increasing awareness about available treatment options are some of the major factors contributing to its growth. Moreover, favorable reimbursement policies for prescription drugs and a large number of product launches are also expected to drive the regional market over the forecast period.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to various initiatives taken by governments across countries such as China and India for tackling cardiovascular diseases (CVDs). For instance, in 2014-2015 academic year, Dr. Reddy’s Laboratories Ltd., India launched a national campaign called “Heart Health Month†which was aimed at creating awareness about CVD prevention among people aged 30 years & above through mass media & other platforms such as seminars & workshops etc.
Growth Factors:
- Increasing incidence of arrhythmia: The increasing incidence of arrhythmia is one of the key growth drivers for the global sotalol drug market. Sotalol is a class III antiarrhythmic agent and helps in restoring the normal heart rhythm. This, in turn, is expected to fuel the demand for sotalol drugs worldwide.
- Rising geriatric population: The global geriatric population is growing at a rapid pace and this is expected to drive the demand for sotalol drugs in the coming years. Elderly people are more prone to develop arrhythmias and other cardiac disorders, which makes them ideal candidates for treatment with sotalol drugs.
- Growing awareness about cardiac diseases: There has been a significant increase in awareness about cardiac diseases among people across the globe in recent years. This has led to an increase in demand for effective treatments such as sotalol drugs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sotalol Drug Market Research Report
By Type
Tablet, Oral Solution, Injection
By Application
Ventricular Arrhythmias, Supraventricular Arrhythmias
By Companies
Bayer HealthCare, Mylan, Arbor Pharmaceuticals, Upsher-Smith Laboratories, AltaThera Pharmaceuticals, Teva, Apotex, Epic Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
134
Number of Tables & Figures
94
Customization Available
Yes, the report can be customized as per your need.
Global Sotalol Drug Market Report Segments:
The global Sotalol Drug market is segmented on the basis of:
Types
Tablet, Oral Solution, Injection
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Ventricular Arrhythmias, Supraventricular Arrhythmias
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer HealthCare
- Mylan
- Arbor Pharmaceuticals
- Upsher-Smith Laboratories
- AltaThera Pharmaceuticals
- Teva
- Apotex
- Epic Pharma
Highlights of The Sotalol Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablet
- Oral Solution
- Injection
- By Application:
- Ventricular Arrhythmias
- Supraventricular Arrhythmias
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sotalol Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sotalol is a drug used to treat heart failure. It works by relaxing the muscles in the heart, which helps to improve blood flow and reduce pressure.
Some of the major players in the sotalol drug market are Bayer HealthCare, Mylan, Arbor Pharmaceuticals, Upsher-Smith Laboratories, AltaThera Pharmaceuticals, Teva, Apotex, Epic Pharma.
The sotalol drug market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Sotalol Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Sotalol Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Sotalol Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Sotalol Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Sotalol Drug Market Size & Forecast, 2018-2028
4.5.1 Sotalol Drug Market Size and Y-o-Y Growth
4.5.2 Sotalol Drug Market Absolute $ Opportunity
Chapter 5 Global Sotalol Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Sotalol Drug Market Size Forecast by Type
5.2.1 Tablet
5.2.2 Oral Solution
5.2.3 Injection
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Sotalol Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Sotalol Drug Market Size Forecast by Applications
6.2.1 Ventricular Arrhythmias
6.2.2 Supraventricular Arrhythmias
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Sotalol Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Sotalol Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Sotalol Drug Analysis and Forecast
9.1 Introduction
9.2 North America Sotalol Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Sotalol Drug Market Size Forecast by Type
9.6.1 Tablet
9.6.2 Oral Solution
9.6.3 Injection
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Sotalol Drug Market Size Forecast by Applications
9.10.1 Ventricular Arrhythmias
9.10.2 Supraventricular Arrhythmias
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Sotalol Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Sotalol Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Sotalol Drug Market Size Forecast by Type
10.6.1 Tablet
10.6.2 Oral Solution
10.6.3 Injection
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Sotalol Drug Market Size Forecast by Applications
10.10.1 Ventricular Arrhythmias
10.10.2 Supraventricular Arrhythmias
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Sotalol Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Sotalol Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Sotalol Drug Market Size Forecast by Type
11.6.1 Tablet
11.6.2 Oral Solution
11.6.3 Injection
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Sotalol Drug Market Size Forecast by Applications
11.10.1 Ventricular Arrhythmias
11.10.2 Supraventricular Arrhythmias
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Sotalol Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Sotalol Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Sotalol Drug Market Size Forecast by Type
12.6.1 Tablet
12.6.2 Oral Solution
12.6.3 Injection
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Sotalol Drug Market Size Forecast by Applications
12.10.1 Ventricular Arrhythmias
12.10.2 Supraventricular Arrhythmias
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Sotalol Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Sotalol Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Sotalol Drug Market Size Forecast by Type
13.6.1 Tablet
13.6.2 Oral Solution
13.6.3 Injection
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Sotalol Drug Market Size Forecast by Applications
13.10.1 Ventricular Arrhythmias
13.10.2 Supraventricular Arrhythmias
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Sotalol Drug Market: Competitive Dashboard
14.2 Global Sotalol Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer HealthCare
14.3.2 Mylan
14.3.3 Arbor Pharmaceuticals
14.3.4 Upsher-Smith Laboratories
14.3.5 AltaThera Pharmaceuticals
14.3.6 Teva
14.3.7 Apotex
14.3.8 Epic Pharma
